Suppr超能文献

增强型单焦点人工晶状体在不同严重程度青光眼患者中的疗效与安全性。

Efficacy and safety of the enhanced monofocal intraocular lens in glaucoma of varying severity.

作者信息

Kim Heesuk, Ahn Junyeong, Seo Minju, Bae Hyoung Won, Kim Chan Yun, Choi Wungrak

机构信息

Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, 50-1, Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.

Yonsei University College of Medicine, Seoul, Republic of Korea.

出版信息

Sci Rep. 2025 Feb 8;15(1):4737. doi: 10.1038/s41598-025-87282-3.

Abstract

This study evaluates the safety and visual outcomes of enhanced monofocal intraocular lenses compared to standard monofocal intraocular lenses in patients with varying severities of glaucoma. Utilizing data from surgeries performed in 2021, the study involved patients aged 40 and older with visually significant cataracts and diagnosed glaucoma or glaucoma suspects. The findings indicate that both enhanced and standard monofocal lenses lead to significant improvements in best-corrected visual acuity, visual field index, mean deviation, and retinal nerve fiber layer thickness postoperatively. No significant differences were observed between the two groups in the extent of these improvements, suggesting that enhanced monofocal lenses may offer a viable alternative for patients with glaucoma, providing significant visual benefits and potentially better intermediate vision while preserving overall visual function.

摘要

本研究评估了与标准单焦点人工晶状体相比,增强型单焦点人工晶状体在不同严重程度青光眼患者中的安全性和视觉效果。该研究利用2021年手术的数据,纳入了年龄在40岁及以上、患有具有视觉意义的白内障且被诊断为青光眼或青光眼疑似患者。研究结果表明,增强型和标准单焦点人工晶状体在术后均能使最佳矫正视力、视野指数、平均偏差和视网膜神经纤维层厚度得到显著改善。两组在这些改善程度上未观察到显著差异,这表明增强型单焦点人工晶状体可能为青光眼患者提供一种可行的替代选择,在保留整体视觉功能的同时提供显著的视觉益处并可能具有更好的中距离视力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f838/11807180/5aecf9254813/41598_2025_87282_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验